GlucoModicum Appoints Peter Gerhardsson to its Board of Directors
Business Finland allocates significant funding to GlucoModicum
GlucoModicum completes successful pilot clinical trials
GlucoModicum completes industrial grade prototype and sensor
GlucoModicum Clinical Trial raises a lot of interest
GlucoModicum closes the next funding round
GlucoModicum has closed +1,2MEUR Seed Round
GlucoModicum closes Pre-Seed funding round
GlucoModicum Ltd is established.
GlucoModicum – Health Design 2017 Winner.